Leading the Way in Life Science Technologies

GEN Exclusives

More »

Feature Articles

More »

For full access to this article login to GEN Select now.

June 15, 2007 (Vol. 27, No. 12)

Reducing Attrition in Late-Stage Development

MipTec Highlights Reveal Industry Focus on Characterization for Turning Hits into Leads

  • Kurt Stoeckli, Ph.D., vp, member of the global discovery board, and head of lead identification technologies, Sanofi-Aventis (www.sanofi-aventis.com) sciences and medical affairs, opened the 10th “MipTec” conference in Basel, Switzerland, last month with a perspective on drug discovery as seen by big pharma. There have been several challenges in ...

Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.

Get GEN Select Access Now

    • Do not put any letters or characters here if you are not a spy program.